Concerns about manipulation and suppression of the clinical research literature are gaining more traction. Recently, Alison Bass published Side Effects , a book that explored one of the more vivid cases.
As described by a reviewer in the New England Journal of Medicine,(1)
She has used the case of Paxil to expose the unsavory and self-serving relationships among members of the pharmaceutical industry, psychiatrists, and members of the FDA.
The reviewer concluded,...
Post new comment